StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CNBX Pharmaceuticals's price to sales ratio was 7.1× on Mar 31, 2025, against 0.9× a year earlier. Over the last 2 years it ranged from 0.0× to 163.7×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Mar 31, 20257.1×+5.3
2024Dec 31, 20241.8×+1.0
2023Dec 29, 20230.8×−76.1
2022Dec 30, 202276.9×–

More CNBX Pharmaceuticals figures

See a number that looks wrong?